Seeking Alpha

Uncommon Profit Investor  

View Uncommon Profit Investor's StockTalks BY TICKER:
  • Uncommon Profit Investor
    Winners And Losers In The Allergan Valeant Actavis Melee; Also, Will Bill Ackman Lose His Profit? $AGN, $VRX http://seekingalpha.com/a/1loln
    11/18/14
    Reply
      • Uncommon Profit Investor
        Digging Deeper Into Valeant's Organic Growth Claims $VRX http://seekingalpha.com/a/1j93n
        10/21/14
        Reply
          • Uncommon Profit Investor
            Thoughts On The Allergan Actavis Valeant Frenzy $AGN, $ACT, $VRX http://seekingalpha.com/a/1imhh
            10/8/14
            Reply
              • Uncommon Profit Investor
                Can Valeant's Glaucoma Drug Peak Sales Be Much Lower Than Claimed? $VRX, $AGN http://seekingalpha.com/a/1i34j
                9/26/14
                Reply
                  • Uncommon Profit Investor
                    Update: Valeant's Q3 Shocker Devoid Of Details; Allergan Claims It Will Win In The Special... $VRX, $AGN http://seekingalpha.com/a/1i00v
                    9/25/14
                    Reply
                      • Uncommon Profit Investor
                        Lessons From The Go-Go Years (One Of Warren Buffett's And Bill Gates's Favorite Business... $AGN, $VRX http://seekingalpha.com/a/1hqk1
                        9/19/14
                        Reply
                          • Uncommon Profit Investor
                            Misleading Statements In The Ruane, Cunniff, Goldfarb Annual Meeting Transcript Regarding... $VRX, $AGN http://seekingalpha.com/a/1gwfb
                            9/3/14
                            Reply
                              • Uncommon Profit Investor
                                How Valeant Continues To Hide Important Financial Data From Investors That Other Pharmas Disclose $VRX, $AGN http://seekingalpha.com/a/1gj77
                                8/26/14
                                Reply
                                  • Uncommon Profit Investor
                                    Update: Allergan Might Acquire Salix Pharmaceuticals Or Someone Else $AGN, $VRX http://seekingalpha.com/a/1g8s7
                                    8/20/14
                                    Reply
                                      • Uncommon Profit Investor
                                        Perrigo Shines Again: Digging Into Perrigo Company's Q4 2014 And FY 2014 Earnings Report $PRGO http://seekingalpha.com/a/1g34l
                                        8/17/14
                                        Reply
                                          • Uncommon Profit Investor
                                            Update: Valeant's Tender Offer For Allergan - Just 4% Of Shares Tendered In Dismal Failure $AGN, $VRX http://seekingalpha.com/a/1g2id
                                            8/17/14
                                            Reply
                                              • Uncommon Profit Investor
                                                Why Tax Inversions Won't Go Away http://seekingalpha.com/a/1fuzj
                                                8/13/14
                                                Reply
                                                  • Uncommon Profit Investor
                                                    Juicy Details From The Allergan Lawsuit: Why Valeant And Ackman May Be In More Trouble Than... $AGN, $VRX http://seekingalpha.com/a/1ey7t
                                                    8/4/14
                                                    Reply
                                                      • Uncommon Profit Investor
                                                        Update: Looks Like Bill Ackman Does Not Have Enough Allergan Shareholder Votes $AGN http://seekingalpha.com/a/1eo83
                                                        7/31/14
                                                        Reply
                                                          • Uncommon Profit Investor
                                                            Ominous Signs For Valeant In The Allergan Q2 Earnings Call $AGN, $VRX http://seekingalpha.com/a/1e16d
                                                            7/23/14
                                                            Reply
                                                              • Uncommon Profit Investor
                                                                What The SEC Should Ask Valeant; Allergan Investors Should Watch Out $VRX, $AGN http://seekingalpha.com/a/1dvfz
                                                                7/21/14
                                                                Reply
                                                                  • Uncommon Profit Investor
                                                                    Who Is Telling The Truth On Fillers: Valeant's CEO Or Allergan's CEO? Is Valeant's Debt A... $VRX, $AGN http://seekingalpha.com/a/1cwvh
                                                                    6/23/14
                                                                    Reply
                                                                      • Uncommon Profit Investor
                                                                        Allergan Should Buy Perrigo For A Tax Inversion; Before Someone Else Does $AGN, $PRGO, $VRX http://seekingalpha.com/a/1cuu5
                                                                        6/20/14
                                                                        Reply
                                                                          • Uncommon Profit Investor
                                                                            Valeant Left Important Questions Unanswered; Allergan Shareholders Beware $AGN, $VRX http://seekingalpha.com/a/1crdp
                                                                            6/18/14
                                                                            Reply
                                                                              • Uncommon Profit Investor
                                                                                Perrigo Can Reach $200 If It Keeps Tysabri Royalties, Lot More If It Sells Them $PRGO http://seekingalpha.com/a/1cien
                                                                                6/11/14
                                                                                Reply